You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead Mar 05, 2024 at 12:02: AM
Administrator
Staff member
via
- Sandoz has acquired Cimerli, a ranibizumab biosimilar.
- The transaction includes the full Cimerli business for $170 million.
article source
